Caricamento...

Predictive biomarkers of response to immune checkpoint inhibitors in melanoma

INTRODUCTION: Advanced melanoma has recently been transformed by the advent of immune checkpoint inhibitors. These agents have altered the prognosis of this disease from a median survival of <1 year to recent data showing a 5-year survival surpassing 50%. Combination regimens combining PD-1 and C...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Expert Rev Anticancer Ther
Autori principali: Nebhan, Caroline A, Johnson, Douglas B
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7040956/
https://ncbi.nlm.nih.gov/pubmed/31997676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2020.1724539
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !